- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04122261
A Clinical Study of Chinese Domestic Surgical Robot
October 21, 2021 updated by: The Third Xiangya Hospital of Central South University
Prospective, Multicenter, Randomized, Single-blind, Parallel-controlled Clinical Trial Protocol for the Safety and Efficacy of Clinical Applications of the Endoscopic Instrument Control System
This is a prospective, multi-center, randomized, single-blind, parallel-controlled clinical trial to evaluate the safety and efficacy of the Chinese domestic endoscopic instrument control system in clinical treatment.
Study Overview
Status
Completed
Conditions
Detailed Description
To evaluate the safety and efficacy of the Chinese domestic endoscopic instrument control system in clinical treatment.This clinical trial is a prospective, multi-center, randomized, single-blind, parallel-controlled study.
The system used in the experimental group is the endoscopic instrument control system developed by WEGO Surgical Robot Co., Ltd., and the system used in the control group is the da Vinci endoscopic instrument control system developed by Intuitive Surgical.
Before patients are enrolled in this clinical study, the researchers will do a detailed screening of the subjects based on the inclusion criteria and the exclusion criteria to determine if the patients are appropriate for the clinical study.
Patients who meet the conditions of the study will be required to sign an informed consent form.
Then they will be randomly assigned to the experimental group or the control group.
To evaluate the primary outcome measures and secondary outcome measures and to observe the incidence of organ and vascular injury.
Finally, we evaluate the safety and efficacy of the test product through the comparison of the data obtained from the experimental group and the control group during the treatment.
Study Type
Interventional
Enrollment (Actual)
168
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410013
- The Third Xiangya Hospital of Central South University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
1. 18-65 years old, male or female
2 .American Society of Anesthesiologists (ASA): Level 1, Level 2 or Level 3
3. BMI 18-30Kg/m2
4. Benign gallbladder diseases such as acute or chronic cholecystitis, gallstones and polypoid lesions of gallbladder
5. Subjects or their legal representatives/guardians voluntarily participate in clinical trials and have signed informed consent form
Exclusion Criteria:
- Participating in any other clinical trial within 30 days before signing the informed consent form
- Pregnancy or lactation
- With a history of epilepsy or psychosis
- With a history of previous operations at related sites
- Severe cardiovascular and cerebrovascular diseases with New York grade III-IV cardiac function or pulmonary insufficiency that can't tolerate the operation
- Severe liver and kidney insufficiency such as cirrhosis and renal failure
- Acute cholecystitis lasting for more than 72 hours, acute cholecystitis with severe complications such as cholecystitis, gangrene, perforation, etc., and gallbladder thickness thicker than 10 mm
- Acute cholangitis, gallstone with acute pancreatitis, primary common bile duct stones, intrahepatic bile duct stones and obstructive jaundice
- Gallbladder cancer or protuberant lesions are suspected to be cancerous
- Severe allergic constitution and suspected or identified addicts to alcohol or drugs
- Abdominal infection, peritonitis, diaphragmatic hernia, severe systemic infection or metastatic diseases
- Other situations that researchers consider it inappropriate to participate in this clinical trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: experimental group
MicroHand S robotic surgery group
|
Using the MicroHand S endoscopic instrument control system to treat gallstone or cholecystitis in minimal invasive surgery.
|
Experimental: control group
da Vinci robotic surgery group
|
Using the da Vinci endoscopic instrument control system to treat gallstone or cholecystitis in minimal invasive surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
surgical success rate
Time Frame: within 24 hours after operation
|
The surgical success rate is defined as the proportion of successfully operative subjects in the experimental group or the control group.
|
within 24 hours after operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The breakage rate of gallbladder
Time Frame: within 12 hours after operation
|
The breakage rate of gallbladder is defined as the proportion of the subjects in the experimental group or the control group with specimen breakage.
|
within 12 hours after operation
|
Comprehensive Complication Index (CCI)
Time Frame: an average of 5 days after operation
|
CCI is calculated using online tools provided by http://cci.assessurgery.com.
Based on the Clavien-Dindo complications grade system (appendix.1),
all complications and adverse events after surgical intervention are taken into consideration.
The overall incidence is measured on a scale ranging from 0 (no complication) to 100 (death).
|
an average of 5 days after operation
|
Operative time
Time Frame: within 12 hours after operation
|
The length of time from the beginning of the operation after the robot installation to the end of the suture of the incision.
|
within 12 hours after operation
|
Intraoperative bleeding
Time Frame: within 12 hours after operation
|
The total bleeding volume from the beginning of the operation to the end of the suture of the incision.
It can be calculated by measuring the blood volume in the vacuum suction device and weighing the gauze after using them to wipe the bleeding.
|
within 12 hours after operation
|
Postoperative pain
Time Frame: within 24 hours after operation
|
Postoperative pain is assessed by visual analogue scale (VAS) 24-26 hours after the operation, ranging from 0 (no pain) to 10 (maximum pain).
|
within 24 hours after operation
|
Time to first flatus
Time Frame: an average of 2 days after operation
|
The time from the end of the operation to the subject's first flatus after surgery.
|
an average of 2 days after operation
|
Surgeon's satisfaction
Time Frame: within 12 hours after operation
|
After the operation, surgeons fill a questionnaire to score the flexibility, intuition and stability of the products, as well as their sense of delay and fatigue when using the products.
Each question in the score ranges from 1 to 5 points and the total score is 100.
|
within 12 hours after operation
|
Installation time
Time Frame: preoperation
|
The time from the power-on of the products to the end of the connection between trocars and the operative arms.
|
preoperation
|
Hospital stay
Time Frame: an average of 5 days after operation
|
The total hospital days of subjects from admission to discharge.
|
an average of 5 days after operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 13, 2019
Primary Completion (Actual)
October 1, 2020
Study Completion (Actual)
October 1, 2021
Study Registration Dates
First Submitted
September 28, 2019
First Submitted That Met QC Criteria
October 9, 2019
First Posted (Actual)
October 10, 2019
Study Record Updates
Last Update Posted (Actual)
October 25, 2021
Last Update Submitted That Met QC Criteria
October 21, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SDWG-NST600S-CT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholecystitis
-
The University of Texas Health Science Center at...CompletedAcute Cholecystitis | Chronic CholecystitisUnited States
-
Azienda Ospedaliero, Universitaria PisanaCompletedAcute CholecystitisItaly
-
University Hospital, GhentCompletedUncomplicated Acute CholecystitisBelgium, Qatar
-
Ain Shams UniversityCompletedCholecystitis | Chronic Calculous Cholecystitis | Acute Calculous CholecystitisEgypt
-
Konya Meram State HospitalCompleted
-
Pirogov Russian National Research Medical UniversityCompletedAcute Cholecystitis | Gangrenous CholecystitisRussian Federation
-
Hospital del MarCompletedAcute Cholecystitis
-
South Valley UniversityCompletedAcute CholecystitisEgypt
-
Asklepios Klinik LangenUniversity Hospital FrankfurtCompletedAcute Cholecystitis
-
University of CataniaCompleted
Clinical Trials on the MicroHand S endoscopic instrument control system
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityThe First Affiliated Hospital of Nanchang University; Chinese PLA General Hospital and other collaboratorsNot yet recruitingEvaluate the Safety and Effectiveness of the Endoscopic Surgical Instrument Control System (SP1000).Urologic NeoplasmsChina
-
Shanghai Operation Robot Co., Ltd.Changhai Hospital; Xuanwu Hospital, Beijing; Tianjin Medical University General...Not yet recruiting
-
The University of Texas Health Science Center,...Completed
-
Clinique du TrocadéroCompleted
-
ResQ Medical LtdNot yet recruitingPPH | Postpartum Hemorrhage \(PPH\) | Postpartum Hemorrhage \(Primary\)Kenya
-
Alydia HealthCompleted
-
University of Kansas Medical CenterCompleted
-
University of VirginiaUnknown
-
Cleveland Clinic LondonRecruitingObesity | Diabetes Mellitus, Type 2United Kingdom
-
Boston Scientific CorporationCompleted